Yu. O. Antuganova
Research Subjects
Yu. O. Antuganova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Dmitrii O. Antuganov
Ministry of Public Health of the Russian Federation
2 shared publications - Andrey Stanzhevskiy
Federal State Budgetary Institution "Russian Scientific Center of Radiology and Surgical Technologies named after Academician A.M. Granov" of the Ministry of Health of the Russian Federation, St. Petersburg, Russia
1 shared publication - Dmitrii N. Maistrenko
Federal State Budgetary Institution «Russian Scientific Center of Radiology and Surgical Technolo-gies named after Academician A. M. Granov» Ministry of Health of the Russian Federation, Sankt-Peterburg
1 shared publication - Dmitry S. Sysoev
Granov Russian Research Center of Radiology and Surgical Technologies
1 shared publication - Ksenija Timofeeva
PET Centre National Almazov Medical Research Centre 2 Akkuratova street 197341 St. Petersburg Russia
1 shared publication - Michail A. Nadporojskii
Granov Russian Research Center of Radiology and Surgical Technologies, 197758 St. Petersburg, Russia
1 shared publication
Latest Publications
- Open Access
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 27-37
68Ga-FAPI-04: the first experience of clinical application in Russia
INTRODUCTION: According to the literature, 68Ga-FAPI-04 has receptor specificity for malignant neoplasms with overexpression of the fibroblast activation protein and is used to visualize various types of neoplasms, in particular head and neck cancer, gastrointestinal tract, lung, breast cancer with a high contrast ratio of the tumor to the background, and may possibly become an alternative to 18F-FDG.OBJECTIVE: The results of the first experience of using PET/CT with 68Ga-FAPI-04 in Russia.MATERIALS AND METHODS: A comparative analysis of the results of 68Ga-FAPI-04 and 18F-FDG PET/CTs with an interval of 1–3 days was carried out in 13 patients (four women and nine men) with various oncological diseases, examined from February to December 2021 in Granov Russian Research Center of Radiology and Surgical Technologies.RESULTS: In all 13 patients, it was possible to identify both primary tumors and their metastases with different tracer uptake. 68Ga-FAPI PET/CT compared with 18F-FDG PET/CT revealed more metastatic foci (135 vs 127) predominantly in the liver, peritoneum, mesentery, omentum, and brain due to low background uptake in these organs. In our observation, foci of increased 68Ga-FAPI-04 uptake localized in non-enlarged retroperitoneal lymph nodes in two patients. Also, in two patients with bone metastases from bladder cancer and stomach cancer, one false positive and one false negative result was obtained with 68Ga-FAPI-04.DISCUSSION: The high uptake of 68Ga-FAPI-04 in the tumor makes it a promising tracer for many types of cancer, especially in cases, where conventional 18F-FDG PET/CT faces limitations due to its pharmacokinetics. At the same time, PET/CT with 68Ga-FAPI-04, aimed at visualizing the tumor microenvironment, may have a higher sensitivity in detecting small lesions due to the predominance of stroma in them. 68Ga-FAPI showed better results in detecting both lytic and osteoblastic bone metastases compared to 18F-FDG.CONCLUSION: 68Ga-FAPI is a promising tracer for molecular imaging of most malignant neoplasms and requires further study. 68Ga-FAPI-04 can become an addition or a full-fledged solution when other tracers have limitations.
- 17 January 2023
- Published by Baltic Medical Education Center in Diagnostic radiology and radiotherapy
- Vol. 13 (4) , 27-37
Open Access68Ga-FAPI-04: the first experience of clinical application in Russia
INTRODUCTION: According to the literature, 68Ga-FAPI-04 has receptor specificity for malignant neoplasms with overexpression of the fibroblast activation protein and is used to visualize various types of neoplasms, in particular head and neck cancer, gastrointestinal tract, lung, breast cancer with a high contrast ratio of the tumor to the background, and may possibly become an alternative to 18F-FDG.OBJECTIVE: The results of the first experience of using PET/CT with 68Ga-FAPI-04 in Russia.MATERIALS AND METHODS: A comparative analysis of the results of 68Ga-FAPI-04 and 18F-FDG PET/CTs with an interval of 1–3 days was carried out in 13 patients (four women and nine men) with various oncological diseases, examined from February to December 2021 in Granov Russian Research Center of Radiology and Surgical Technologies.RESULTS: In all 13 patients, it was possible to identify both primary tumors and their metastases with different tracer uptake. 68Ga-FAPI PET/CT compared with 18F-FDG PET/CT revealed more metastatic foci (135 vs 127) predominantly in the liver, peritoneum, mesentery, omentum, and brain due to low background uptake in these organs. In our observation, foci of increased 68Ga-FAPI-04 uptake localized in non-enlarged retroperitoneal lymph nodes in two patients. Also, in two patients with bone metastases from bladder cancer and stomach cancer, one false positive and one false negative result was obtained with 68Ga-FAPI-04.DISCUSSION: The high uptake of 68Ga-FAPI-04 in the tumor makes it a promising tracer for many types of cancer, especially in cases, where conventional 18F-FDG PET/CT faces limitations due to its pharmacokinetics. At the same time, PET/CT with 68Ga-FAPI-04, aimed at visualizing the tumor microenvironment, may have a higher sensitivity in detecting small lesions due to the predominance of stroma in them. 68Ga-FAPI showed better results in detecting both lytic and osteoblastic bone metastases compared to 18F-FDG.CONCLUSION: 68Ga-FAPI is a promising tracer for molecular imaging of most malignant neoplasms and requires further study. 68Ga-FAPI-04 can become an addition or a full-fledged solution when other tracers have limitations.
- 6 December 2018
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (5) , 918-922
Copper‐Mediated Radiofluorination of Aryl Pinacolboronate Esters: A Straightforward Protocol by Using Pyridinium Sulfonates
Radiofluorination of arylboronic acids pinacol esters (arylBPin) mediated by copper triflate pyridine complex is one of the more promising synthetic approaches for the direct introduction of nucleophilic [18F]fluoride into non‐activated arenes and heteroarenes. However, the application of this method to the production of positron emission tomography (PET) radiotracers in automated synthesizers remains a challenging task. The choice of phase‐transfer catalyst (PTC) and corresponding base used for the generation of reactive [18F]fluoride species has a profound impact on the efficiency of the 18F‐fluorination process. Herein we report the development of a simple procedure involving trapping of the aqueous [18F]fluoride on a weak anion‐exchange resin (WAX) and its release by elution with pyridinium sulfonate in dimethyl acetamide. Obtained reactive [18F]fluoride was used as‐is in a copper‐catalyzed fluorination reaction employing pyridinium salt as both PTC and base. High radiochemical conversion rates (RCCs) achieved for a series of simple arylBPin substrates and 4‐[18F]fluoro‐D,L‐phenylalanine demonstrate the efficiency of this novel 18F‐processing approach. Notably, the proposed method obviates conventional azeotropic drying steps, solvents evaporation and/or changeover and can be implemented on commercial automated synthesizers.
- 6 December 2018
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2019 (5) , 918-922
Copper‐Mediated Radiofluorination of Aryl Pinacolboronate Esters: A Straightforward Protocol by Using Pyridinium Sulfonates
Radiofluorination of arylboronic acids pinacol esters (arylBPin) mediated by copper triflate pyridine complex is one of the more promising synthetic approaches for the direct introduction of nucleophilic [18F]fluoride into non‐activated arenes and heteroarenes. However, the application of this method to the production of positron emission tomography (PET) radiotracers in automated synthesizers remains a challenging task. The choice of phase‐transfer catalyst (PTC) and corresponding base used for the generation of reactive [18F]fluoride species has a profound impact on the efficiency of the 18F‐fluorination process. Herein we report the development of a simple procedure involving trapping of the aqueous [18F]fluoride on a weak anion‐exchange resin (WAX) and its release by elution with pyridinium sulfonate in dimethyl acetamide. Obtained reactive [18F]fluoride was used as‐is in a copper‐catalyzed fluorination reaction employing pyridinium salt as both PTC and base. High radiochemical conversion rates (RCCs) achieved for a series of simple arylBPin substrates and 4‐[18F]fluoro‐D,L‐phenylalanine demonstrate the efficiency of this novel 18F‐processing approach. Notably, the proposed method obviates conventional azeotropic drying steps, solvents evaporation and/or changeover and can be implemented on commercial automated synthesizers.